Geospiza has been around the block a time or two in the bioinformatics business, and after 14 years in the game, it has come to the end of the road.
The Seattle-based company, which makes software for scientists who analyze data from genetic experiments, said last week it has agreed to be acquired by Waltham-based PerkinElmer, the giant . . . → Read More: PerkinElmer links up with bioinformatics firm
A broad research coalition has formally weighed in on the stem cell case, urging Chief Judge Royce Lamberth to suspend his injunction last week halting human embryonic stem cell research. Lamberth faces a Tuesday deadline to make his decision after the Department of Justice (DOJ) on 31 August asked for an emergency stay. Late this afternoon, with . . . → Read More: Stem Cell Case Has ‘Immediate and Devastating’ Impact, Says Research Group
National Institutes of Health (NIH) Director Francis Collins said in a press call this afternoon that yesterday’s court injunction blocking federally funded research on human embryonic stem cells (hESCs) will not affect grant payments that have already gone out the door this year. That’s good news for scores of investigators who worried that their experiments would . . . → Read More: NIH Director Collins Says Cell Ruling Won’t Halt Most Ongoing Grants